Your session is about to expire
← Back to Search
Mapping
Model Based Fast Anatomical Mapping (MFAM Trial)
N/A
Waitlist Available
Led By Subbarao Choudry, MD
Research Sponsored by Vivek Reddy
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during the procedure up to 60 minutes
Awards & highlights
No Placebo-Only Group
Summary
This trial will test if mFAM can quickly create a detailed 3D map of the heart's left atrium for patients with atrial fibrillation needing ablation. The goal is to make the procedure faster and safer by reducing X-ray exposure. mFAM is a new module recently developed for the CARTO system which uses machine learning techniques to map the left atrium.
Eligible Conditions
- Atrial Fibrillation
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ during the procedure up to 60 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during the procedure up to 60 minutes
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
mMap Scoring Questionnaire
Secondary study objectives
Fluoroscopy Time
Left Atrial Geometry Creation Time
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: MFAMExperimental Treatment1 Intervention
The mFAM Workstation is a computerized system used to reconstruct the shape of the left atrium of the heart, by fitting a parametric shape model to points data acquired by a catheter.
The mFAM Workstation uses recorded catheter positions and other data inputs collected from various types of multi-electrode catheters and generates output data files that can be displayed as a 3D anatomic structure.
Find a Location
Who is running the clinical trial?
Vivek ReddyLead Sponsor
20 Previous Clinical Trials
5,288 Total Patients Enrolled
10 Trials studying Atrial Fibrillation
1,007 Patients Enrolled for Atrial Fibrillation
Biosense Webster, Inc.Industry Sponsor
126 Previous Clinical Trials
36,954 Total Patients Enrolled
85 Trials studying Atrial Fibrillation
28,871 Patients Enrolled for Atrial Fibrillation
Subbarao Choudry, MDPrincipal InvestigatorIcahn School of Medicine at Mount Sinai
Mohit Turagam, MDPrincipal InvestigatorIcahn School of Medicine at Mount Sinai
Vivek Reddy, MDStudy ChairIcahn School of Medicine at Mount Sinai
35 Previous Clinical Trials
12,911 Total Patients Enrolled
19 Trials studying Atrial Fibrillation
7,457 Patients Enrolled for Atrial Fibrillation